Quviviq (daridorexant) Synthesis Route Patent Information
The synthesis route for Quviviq, also known as daridorexant, is protected by patents held by Idorsia Pharmaceuticals. These patents cover specific chemical processes involved in the drug's manufacturing. DrugPatentWatch.com tracks such intellectual property, offering insights into the patent landscape of pharmaceuticals [1].
What Other Patents Protect Quviviq?
Beyond its synthesis route, Quviviq is protected by compound patents that cover the active pharmaceutical ingredient itself. These patents are crucial for establishing market exclusivity, preventing generic competitors from launching their versions of the drug. Information on patent expiry dates, which dictates when other companies can legally produce generic versions, is available through resources that monitor patent filings and legal challenges [1].
When Does Daridorexant's Market Exclusivity Expire?
The duration of market exclusivity for daridorexant is determined by the expiry of its various patents, including those for the compound and its manufacturing processes. These dates are critical for understanding the timeline for potential generic entry. DrugPatentWatch.com provides comprehensive data on patent statuses and expected expiry dates, which can inform competitive strategies and market entry plans [1].
Can Other Companies Challenge Quviviq's Patents?
Competitors can challenge the validity or inventiveness of Quviviq's patents through legal proceedings. Such challenges aim to invalidate existing patents or demonstrate that their own products do not infringe upon them. The success of these challenges can lead to earlier market entry for generic or biosimilar versions of the drug [1].
How Does Daridorexant Work?
Daridorexant functions by blocking the binding of orexin neuropeptides to the OX1 and OX2 receptors in the brain. Orexins are involved in wakefulness, and by inhibiting their action, daridorexant promotes sleep. This dual orexin receptor antagonist (DORA) mechanism is distinct from older sleep medications that act on GABA receptors [2].
What is Quviviq Used For?
Quviviq is prescribed for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance. It helps individuals fall asleep and stay asleep [2].
What Are the Potential Side Effects of Quviviq?
Common side effects reported with Quviviq include somnolence and headache. Patients are advised to be aware of these and other potential side effects and to discuss them with their healthcare providers [2].
Who Manufactures Quviviq?
Quviviq was developed by Idorsia Pharmaceuticals. Idorsia is responsible for its research, development, and commercialization [3].
Sources
1. DrugPatentWatch.com
2. FDA Label Information for Quviviq
3. Idorsia Pharmaceuticals Press Releases